SCHEMBL5731346

SCHEMBL5731346

OC(F)(c1ccccc1)C1CO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.40
CYP2D6 P10635 2/20 0.40
MEN1 O00255 1/20 0.40
HRH1 P35367 1/20 0.40
SCN1A P35498 1/20 0.40
KMT2A Q03164 1/20 0.40
SCN2A Q99250 1/20 0.40
SCN3A Q9NY46 1/20 0.40
PTPN1 P18031 1/20 0.38
MAPK1 P28482 2/20 0.37
CYP3A4 P08684 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
RAB9A P51151 1/20 0.37
SLC6A2 P23975 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4889913 0.80 LMNA (0.48) TSHRALDH1A1LMNACYP2D6MEN1
SCHEMBL761287 0.80 TSHR (0.38) TSHRALDH1A1LMNACYP2D6MEN1
SCHEMBL27263148 0.78 CYP2D6 (0.42) TSHRALDH1A1LMNACYP2D6MEN1
SCHEMBL14003863 0.77 MAPK1 (0.42) TSHRALDH1A1LMNACYP2D6MEN1
SCHEMBL10679246 0.74 TSHR (0.42) TSHRALDH1A1LMNACYP2D6MEN1
SCHEMBL8068587 0.73 CYP2D6 (0.39) TSHRALDH1A1LMNACYP2D6MEN1
SCHEMBL30825836 0.73 TSHR (0.42) TSHRALDH1A1LMNACYP2D6MEN1
SCHEMBL30825821 0.73 TSHR (0.42) TSHRALDH1A1LMNACYP2D6MEN1
SCHEMBL1008632 0.72 LMNA (0.42) TSHRALDH1A1LMNACYP2D6MEN1
SCHEMBL10675379 0.71 L3MBTL1 (0.53) TSHRLMNACYP2D6MEN1HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732887-A1 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1-PHENYL PROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE NOREPINEPHRINE (NE) AND THE SEROTONINE (5-HT) ACTIVITY AND THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) Wyeth (US) 2006-12-20 EP disclosed
WO-2005097744-A1 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1-PHENYL PROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE NOREPINEPHRINE (NE) AND THE SEROTONINE (5-HT) ACTIVITY AND THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) WYETH (US) 2005-10-20 WO disclosed